CN1059333C - Chinese patent medicine for treating various cancers and tumors - Google Patents
Chinese patent medicine for treating various cancers and tumors Download PDFInfo
- Publication number
- CN1059333C CN1059333C CN96109333A CN96109333A CN1059333C CN 1059333 C CN1059333 C CN 1059333C CN 96109333 A CN96109333 A CN 96109333A CN 96109333 A CN96109333 A CN 96109333A CN 1059333 C CN1059333 C CN 1059333C
- Authority
- CN
- China
- Prior art keywords
- parts
- root
- chinese patent
- decocting
- portions
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000003814 drug Substances 0.000 title claims abstract description 51
- 206010028980 Neoplasm Diseases 0.000 title claims abstract description 39
- 239000002994 raw material Substances 0.000 claims abstract description 14
- 239000000203 mixture Substances 0.000 claims abstract description 9
- 229940079593 drug Drugs 0.000 claims description 22
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 19
- 241000972149 Urochloa mosambicensis Species 0.000 claims description 14
- 241001290726 Peristrophe Species 0.000 claims description 13
- 239000007788 liquid Substances 0.000 claims description 12
- 241000402754 Erythranthe moschata Species 0.000 claims description 11
- 244000302512 Momordica charantia Species 0.000 claims description 11
- 235000009811 Momordica charantia Nutrition 0.000 claims description 11
- 235000009812 Momordica cochinchinensis Nutrition 0.000 claims description 11
- 235000018365 Momordica dioica Nutrition 0.000 claims description 11
- 240000004371 Panax ginseng Species 0.000 claims description 11
- 235000002789 Panax ginseng Nutrition 0.000 claims description 11
- 244000153955 Reynoutria sachalinensis Species 0.000 claims description 11
- 235000003202 Reynoutria sachalinensis Nutrition 0.000 claims description 11
- 235000008434 ginseng Nutrition 0.000 claims description 11
- 239000002775 capsule Substances 0.000 claims description 10
- 238000002360 preparation method Methods 0.000 claims description 10
- 240000001899 Murraya exotica Species 0.000 claims description 9
- 235000008766 Murraya exotica Nutrition 0.000 claims description 9
- 235000009696 Murraya paniculata Nutrition 0.000 claims description 9
- 241001453732 Odontosoria chinensis Species 0.000 claims description 9
- 201000011510 cancer Diseases 0.000 claims description 8
- JZWFDVDETGFGFC-UHFFFAOYSA-N salacetamide Chemical group CC(=O)NC(=O)C1=CC=CC=C1O JZWFDVDETGFGFC-UHFFFAOYSA-N 0.000 claims description 7
- 241000218211 Maclura Species 0.000 claims description 6
- 241000046617 Aristolochia debilis Species 0.000 claims description 5
- 238000001914 filtration Methods 0.000 claims description 3
- 238000007789 sealing Methods 0.000 claims description 3
- 238000002791 soaking Methods 0.000 claims description 3
- 230000001954 sterilising effect Effects 0.000 claims description 3
- 240000003705 Senecio vulgaris Species 0.000 claims description 2
- 241000219793 Trifolium Species 0.000 claims description 2
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 239000002552 dosage form Substances 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract description 11
- 206010006187 Breast cancer Diseases 0.000 abstract description 4
- 208000026310 Breast neoplasm Diseases 0.000 abstract description 4
- 208000005016 Intestinal Neoplasms Diseases 0.000 abstract description 4
- 208000005718 Stomach Neoplasms Diseases 0.000 abstract description 4
- 206010017758 gastric cancer Diseases 0.000 abstract description 4
- 201000002313 intestinal cancer Diseases 0.000 abstract description 4
- 201000011549 stomach cancer Diseases 0.000 abstract description 4
- 241000411851 herbal medicine Species 0.000 abstract description 3
- 230000001225 therapeutic effect Effects 0.000 abstract description 3
- 208000017520 skin disease Diseases 0.000 abstract description 2
- 208000012991 uterine carcinoma Diseases 0.000 abstract 1
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 8
- 230000000694 effects Effects 0.000 description 6
- 238000000034 method Methods 0.000 description 4
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 4
- 229960004889 salicylic acid Drugs 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- 206010027476 Metastases Diseases 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 201000007270 liver cancer Diseases 0.000 description 3
- 208000014018 liver neoplasm Diseases 0.000 description 3
- 230000009401 metastasis Effects 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- 239000004575 stone Substances 0.000 description 3
- 206010009944 Colon cancer Diseases 0.000 description 2
- 208000000461 Esophageal Neoplasms Diseases 0.000 description 2
- 241000691155 Pteris multifida Species 0.000 description 2
- 208000002495 Uterine Neoplasms Diseases 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 238000002512 chemotherapy Methods 0.000 description 2
- 208000029742 colonic neoplasm Diseases 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 201000004101 esophageal cancer Diseases 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 239000012535 impurity Substances 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 208000010125 myocardial infarction Diseases 0.000 description 2
- 230000008506 pathogenesis Effects 0.000 description 2
- 239000006187 pill Substances 0.000 description 2
- 238000007873 sieving Methods 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 229940126585 therapeutic drug Drugs 0.000 description 2
- 206010046766 uterine cancer Diseases 0.000 description 2
- 229940126673 western medicines Drugs 0.000 description 2
- 235000011299 Brassica oleracea var botrytis Nutrition 0.000 description 1
- 240000003259 Brassica oleracea var. botrytis Species 0.000 description 1
- 208000035240 Disease Resistance Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- GHASVSINZRGABV-UHFFFAOYSA-N Fluorouracil Chemical compound FC1=CNC(=O)NC1=O GHASVSINZRGABV-UHFFFAOYSA-N 0.000 description 1
- 241000756137 Hemerocallis Species 0.000 description 1
- 102000014150 Interferons Human genes 0.000 description 1
- 108010050904 Interferons Proteins 0.000 description 1
- 102000015696 Interleukins Human genes 0.000 description 1
- 108010063738 Interleukins Proteins 0.000 description 1
- 241001514662 Leptospermum Species 0.000 description 1
- 208000032023 Signs and Symptoms Diseases 0.000 description 1
- 208000000453 Skin Neoplasms Diseases 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 229940041181 antineoplastic drug Drugs 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- DQLATGHUWYMOKM-UHFFFAOYSA-L cisplatin Chemical compound N[Pt](N)(Cl)Cl DQLATGHUWYMOKM-UHFFFAOYSA-L 0.000 description 1
- 229960004316 cisplatin Drugs 0.000 description 1
- 235000021270 cold food Nutrition 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 235000013601 eggs Nutrition 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 229960002949 fluorouracil Drugs 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 235000021059 hard food Nutrition 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- -1 impact Substances 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 229940079322 interferon Drugs 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 201000000849 skin cancer Diseases 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 230000004206 stomach function Effects 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 206010042772 syncope Diseases 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 239000009333 tian-xian Substances 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
The invention relates to a pharmaceutical composition for treating various cancers and tumors, in particular to a pure traditional Chinese medicine composition for treating various cancers and tumors, which is prepared by taking plant Chinese herbal medicines as raw materials. Has special therapeutic effects on dermatoses, breast cancer, carcinoma of uterus, gastric cancer, hepatocarcinoma, and intestinal cancer.
Description
The invention relates to a pharmaceutical composition for treating various cancers and tumors, in particular to a pure traditional Chinese medicine composition for treating various cancers and tumors, which is prepared by taking plant Chinese herbal medicines as raw materials and has special treatment effects on skin diseases, breast cancer, uterine cancer, gastric cancer, liver cancer, intestinal cancer and the like.
According to the statistics of the world health organization, the incidence of various cancers and tumors tends to rise year by year, and particularly liver cancer, gastric cancer, breast cancer, uterine cancer, intestinal cancer and the like have the greatest threat to human health. So far, no specific good medicine for treating cancers and tumors exists in the world, the current treatment method is a comprehensive treatment measure of performing operation treatment, chemotherapy and combination of Chinese medicines and western medicines on early and middle cancer and tumor patients, the treatment method only plays a role in relieving symptoms although a certain curative effect is obtained, and a particularly effective treatment method is lacked for late malignant tumor patients. Common anticancer western medicines comprise interferon, interleukin, cisplatin, 5-fluorouracil and the like, and the medicines have undesirable effects and large side effects; the commonly used traditional Chinese medicine anticancer drugs are generally targeted therapeutic drugs, for example, compound Tianxian pills are therapeutic drugs for digestive tract cancer, and at present, drugs capable of treating various cancers and tumors are lacked.
The invention aims to provide a traditional Chinese medicine composition capable of effectively treating various cancers and tumors.
The technical scheme of the invention is that according to the understanding of the traditional Chinese medicine on the pathogenesis and the treatment principle of the occurrence, development and metastasis of cancer and tumor, and the knowledge of modern pharmacology, the Chinese herbal medicine composition is screened from the medical treasury of China, has no side effect, can inhibit the development (recurrence and metastasis) of tumor, maintains the overall function of the organism, can promote blood circulation to remove blood stasis, regulate vital energy to relieve pain, soften hardness to dissipate stagnation, clear away heat and toxic materials, and strengthen the body resistance to consolidate the constitution.
The pharmaceutical composition comprises the following components in parts by weight:
musk 6-12 parts
6-15 parts of black syncope
Peristrophe root 15-25 parts
15-25 parts of murraya paniculata
20-30 parts of Aristolochia debilis
6-15 parts of giant knotweed
20-30 parts of herringbone grass
35-45 parts of phoenix-tail fern root
6-12 parts of mountain balsam pear
25-35 parts of salicyl
20-30 parts of cudrania root
25-35 parts of Korean ginseng
The preferred weight ratio of each component of the pharmaceutical composition is as follows:
musk 7-10 parts
8-12 parts of Stenoloma chusanum (Linn.) Ching
18-22 parts of Japanese peristrophe herb root
18-22 parts of murraya paniculata
22-28 parts of Aristolochia debilis
8-12 parts of giant knotweed
22-28 parts of herringbone grass
38-42 parts of phoenix-tail fern root
8-12 parts of mountain balsam pear
28-32 parts of salicyl
22-28 parts of radix cudraniae
28-32 parts of Korean ginseng
The optimal weight ratio of the pharmaceutical composition of the invention is as follows:
musk 8 parts
10 portions of Stenoloma chusanum (Linn.) Ching
20 portions of Japanese peristrophe root
20 parts of murraya paniculata
25 portions of bird seed
10 portions of giant knotweed
25 parts of herringbone grass
40 parts of phoenix-tail fern root
Mountain balsam pear 10 parts
30 portions of salicyl
25 portions of cudrania root
Korean ginseng 30 parts
The components are recorded in a Chinese medicine dictionary, and any medicine recorded by the name can achieve the aim of the invention, wherein the herringbone grass is preferably clover herringbone grass.
The pharmaceutical composition can be prepared into any medicament according to the conventional pharmaceutical preparation process, such as oral liquid, capsules, tablets, pills, powder, impact, paste, infusion and the like.
The preparation method of the capsule of the medicine of the invention comprises the following steps:
according to the composition of the pharmaceutical composition, the raw materials are selected, dried, crushed, sieved by a 100-mesh sieve and encapsulated to obtain the pharmaceutical composition.
Or,
according to the composition of the pharmaceutical composition, the raw materials are selected and decocted with water twice, the first time of water addition is 3-5 times of the crude drug amount and is decocted for 1-2 hours, the second time of water addition is 2-4 times of the crude drug amount and is decocted for 0.5-1.5 hours, the two decocted liquids are combined, filtered and concentrated into dry extract, the dry extract is crushed into fine powder, and the fine powder is filled into capsules, wherein each capsule is 2 g.
The preparation method of the medicine oral liquid comprises the following steps:
according to the composition of the pharmaceutical composition, the raw materials are selected, soaked in water for 2 hours, decocted for three times, the first time of water addition is 3-5 times of the crude drug amount, decocted for 1-2 hours, the second time of water addition is 2-4 times of the crude drug amount, decocted for 0.5-1.5 hours, the third time of water addition is 2-3 times of the crude drug amount, decocted for 0.5-1 hour, the three decocted fluids are combined, decocted for 1 hour again, filtered, sterilized at 100 ℃ for 30 minutes, subpackaged and sealed, and the pharmaceutical composition is obtained.
The medicine has the functions of promoting blood circulation to remove blood stasis, regulating qi to alleviate pain, conditioning liver and spleen and strengthening body resistance, improves the symptoms of tumor patients, gradually reduces and disappears tumors, can inhibit tumor metastasis, enhances the organism immunity of the patients and improves the survival rate of the tumor patients.
The medicine has the important characteristics that the spleen and the stomach are regulated to keep the acquired constitution, the disease resistance of the organism is enhanced, the body resistance is hoped to be strengthened and the evil is eliminated, the local tumor can be eliminated and the whole function of the organism can be regulated, so that the disease condition of some cancer patients can be relieved to different degrees, and the symptoms of the individual cancer patients can disappear; the second characteristic of the invention is that based on the principle of dialectical treatment of traditional Chinese medicine, on the basis of the Chinese patent medicine preparation of the invention, the invention is added or subtracted according to different pathogenesis of various cancers and tumors, and the invention can respectively have better curative effect on liver cancer, stomach cancer, esophagus cancer, skin cancer, breast cancer, intestinal cancer and the like.
The application method of the medicine of the invention is as follows:
for patients with early and middle stage tumor, the oral liquid is taken twice a day, 50 ml each time, and the capsule is taken twice a day, 2 capsules each time, and two months are a course of treatment. The oral liquid is taken by a patient with advanced malignant tumor three times a day, 80 milliliters of the oral liquid each time, 3 times a day, 4 capsules each time, and one month is a treatment course. Before, during and after taking the medicine, the patient should be observed the symptoms and signs, liver and stomach functions, tumor size, sign changes, etc. before, during and after taking the medicine, the patient is prohibited to eat cold and hard food, beef, mutton, eggs, day lily, cauliflower, rape, etc.
Therapeutic example 1
The male, 58 years old, suffered from esophagus cancer, had poor curative effect through chemotherapy in a plurality of hospitals, was maintained life by transfusion, was extremely weak, and then was taken 3 times a day, 80 ml each time, and was returned to eating after one month, so that the patient can normally move.
Therapeutic example 2
For men, 64 years old and colon cancer patients, who suffer from myocardial infarction and serious diabetes simultaneously and can not be resected by operation, after the oral liquid of the invention is taken for 40 days continuously, the oral liquid of the invention is taken 3 times a day, 80 ml each time, so that the colon cancer of the patients can be controlled, the focus is reduced, the stool is unobstructed, and the symptoms of myocardial infarction and diabetes are improved.
Example 1
Prescription:
musk 6 g
Stenoloma chusanum (Chin.) Ching 6 g
Peristrophe root 15 g
Jiuliguang (15 g)
Bird does not step on 20 g
Giant knotweed rhizome, rhizoma Polygoni Cuspidati 6 g
20 g of Chinese herring-bone grass
Chinese brake herb root 35 g
Mountain balsam pear 6 g
Salicylic acid 25 g
Ningshao stone 20 g
Korean ginseng 25 g
The preparation method comprises the following steps:
selecting raw materials, soaking in water for 2 hours, decocting for three times, wherein the water addition amount for the first time is 3 times of the crude drug amount, decocting for 1 hour, the water addition amount for the second time is 2 times of the crude drug amount, decocting for 0.5 hour, the water addition amount for the third time is 2 times of the crude drug amount, decocting for 0.5 hour, combining the decoction liquids for three times, decocting for 1 hour again, filtering, sterilizing at 100 ℃ for 30 minutes, subpackaging and sealing to obtain the traditional Chinese medicine composition.
Example 2
Prescription:
musk 12 g
Wujue 15 g
Peristrophe root, radix peristrophes 25 g
Jiuliguang (25 g)
Bird does not step on 30 g
Giant knotweed rhizome, rhizoma Polygoni Cuspidati 15 g
30 g of herringbone grass
Chinese brake herb root 45 g
Mountain balsam pear 12 g
Salicylic acid 35 g
Chuanshao stone 30 g
Korean ginseng 35 g
The preparation method comprises the following steps:
selecting raw materials, soaking in water for 2 hours, decocting for three times, wherein the water addition amount for the first time is 5 times of the crude drug amount, decocting for 2 hours, the water addition amount for the second time is 4 times of the crude drug amount, decocting for 1.5 hours, the water addition amount for the third time is 2 times of the crude drug amount, decocting for 0.5 hour, combining the decoction liquids for three times, decocting for 1 hour again, filtering, sterilizing at 100 ℃ for 30 minutes, subpackaging and sealing to obtain the traditional Chinese medicine.
Example 3
Prescription:
musk 8 g
Stenoloma chusanum (Linn.) Ching 10 g
Peristrophe root 20 g
20 g of murraya paniculata
Bird does not step on 25 g
Giant knotweed rhizome 10 g
Chinese herring-bone grass 25 g
40 g of phoenix-tail fern root
Mountain balsam pear 10 g
Salicylic acid 30 g
Chuanshao stone 25 g
Korean ginseng 30 g
The preparation method comprises the following steps:
selecting raw materials, selecting to remove impurities, drying, crushing, sieving with a 100-mesh sieve, and encapsulating, wherein each capsule is 2 g.
Example 4
Prescription:
musk 10 g
Stenoloma chusanum (Linn.) Ching 12 g
Peristrophe root, radix peristrophes 22 g
Murraya paniculata 22 g
Bird does not step on 28 g
Giant knotweed rhizome, rhizoma Polygoni Cuspidati 12 g
28 g of herringbone grass
Root of Leptospermum japonicum 42 g
Mountain balsam pear 12 g
Salicylic acid 32 g
Chuankuishan (a herb of Cudrania) 28 g
Korean ginseng 32 g
The preparation method comprises the following steps:
selecting raw materials, selecting to remove impurities, drying, crushing, sieving with a 100-mesh sieve, and encapsulating, wherein each capsule is 2 g.
Claims (7)
1. The Chinese patent medicine for treating the cancer and the tumor is characterized by being prepared from the following raw material medicines in parts by weight:
musk 6-12 parts
6-15 parts of Stenoloma chusanum (Linn.) Ching
Peristrophe root 15-25 parts
15-25 parts of murraya paniculata
20-30 parts of Aristolochia debilis
6-15 parts of giant knotweed
20-30 parts of herringbone grass
35-45 parts of phoenix-tail fern root
6-12 parts of mountain balsam pear
25-35 parts of salicyl
20-30 parts of cudrania root
25-35 parts of Korean ginseng.
2. The Chinese patent medicine according to claim 1, characterized in that it is prepared from the following raw material medicines in parts by weight:
musk 7-10 parts
8-12 parts of Stenoloma chusanum (Linn.) Ching
18-22 parts of Japanese peristrophe herb root
18-22 parts of murraya paniculata
22-28 parts of Aristolochia debilis
8-12 parts of giant knotweed
22-28 parts of herringbone grass
38-42 parts of phoenix-tail fern root
8-12 parts of mountain balsam pear
28-32 parts of salicyl
22-28 parts of radix cudraniae
28-32 parts of Korean ginseng.
3. The Chinese patent medicine according to claim 1, characterized in that it is prepared from the following raw material medicines in parts by weight:
musk 8 parts
10 portions of Stenoloma chusanum (Linn.) Ching
20 portions of Japanese peristrophe root
20 parts of murraya paniculata
25 portions of bird seed
10 portions of giant knotweed
25 parts of herringbone grass
40 parts of phoenix-tail fern root
Mountain balsam pear 10 parts
30 portions of salicyl
25 portions of cudrania root
30 parts of Korean ginseng.
4. A Chinese patent drug according to claim 1, 2 or 3, characterized in that said herringbone grass is clover.
5. A Chinese patent drug according to claim 1, 2 or 3, characterized in that the form of the drug is any clinically acceptable agent.
6. The Chinese patent medicine according to claim 5, characterized in that the dosage form of the medicine is capsule or oral liquid.
7. The Chinese patent medicine according to claim 1, characterized in that the preparation method comprises:
musk 6-12 parts
6-15 parts of Stenoloma chusanum (Linn.) Ching
Peristrophe root 15-25 parts
15-25 parts of murraya paniculata
20-30 parts of Aristolochia debilis
6-15 parts of giant knotweed
20-30 parts of herringbone grass
35-45 parts of phoenix-tail fern root
6-12 parts of mountain balsam pear
25-35 parts of salicyl
20-30 parts of cudrania root
25-35 parts of Korean ginseng.
The preparation method comprises the following steps of selecting raw materials, soaking the raw materials in water for 2 hours, decocting for three times, wherein the water adding amount for the first time is 3-5 times of the crude drug amount, decocting for 1-2 hours, the water adding amount for the second time is 2-4 times of the crude drug amount, decocting for 0.5-1.5 hours, the water adding amount for the third time is 2-3 times of the crude drug amount, decocting for 0.5-1 hour, combining the decoction liquids obtained in the three times, decocting for 1 hour again, filtering, sterilizing at 100 ℃ for 30 minutes, subpackaging and sealing to obtain the traditional Chinese medicine composition.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN96109333A CN1059333C (en) | 1996-09-20 | 1996-09-20 | Chinese patent medicine for treating various cancers and tumors |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN96109333A CN1059333C (en) | 1996-09-20 | 1996-09-20 | Chinese patent medicine for treating various cancers and tumors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1147397A CN1147397A (en) | 1997-04-16 |
| CN1059333C true CN1059333C (en) | 2000-12-13 |
Family
ID=5120337
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN96109333A Expired - Fee Related CN1059333C (en) | 1996-09-20 | 1996-09-20 | Chinese patent medicine for treating various cancers and tumors |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1059333C (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7189419B2 (en) * | 2002-12-17 | 2007-03-13 | Avon Products, Inc. | Use of active extracts to lighten skin, lips, hair, and/or nails |
| CN1935228B (en) * | 2006-06-30 | 2011-07-27 | 杨雄志 | Chinese medicine composition for preventing and treating breast cancer and its preparation method |
| CN101229348B (en) * | 2008-01-30 | 2010-09-29 | 薛福社 | Chinese traditional medicine compounds for treating tumour and preparing method thereof |
| CN103610063B (en) * | 2013-12-05 | 2015-01-14 | 成都乾唐农业科技有限责任公司 | Kenneth Lonergan marrow mixture and preparation method thereof |
-
1996
- 1996-09-20 CN CN96109333A patent/CN1059333C/en not_active Expired - Fee Related
Non-Patent Citations (3)
| Title |
|---|
| 中医杂志1992,33(7) 1992.7.31 杨更录等，癌症镇痛散治疗癌性疼痛临床研究 * |
| 山东中医杂志1992,1(5) 1992.5.31 赵锡民等，消癌痛合复原汤治疗癌症五十例 * |
| 山东中医杂志1992,1(5) 1992.5.31 赵锡民等，消癌痛合复原汤治疗癌症五十例;中医杂志1992,33(7) 1992.7.31 杨更录等，癌症镇痛散治疗癌性疼痛临床研究 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1147397A (en) | 1997-04-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1084206C (en) | Cancer treating medicine and its preparation | |
| CN1840166A (en) | Modern Chinese medicinal oral liquid of 'Wen Dan Tang' and preparation method thereof | |
| CN1305513C (en) | Broad-spectrum cancer-treating Chinese medicine prepn and its prepn process | |
| CN1290550C (en) | Chinese medicine composition for treating rheumatism, rheumatoid, hyperosteogeny and fracture and preparing method thereof | |
| CN1059333C (en) | Chinese patent medicine for treating various cancers and tumors | |
| CN1927331A (en) | Chinese medicine preparation for curing chronic heart failure | |
| CN1478508A (en) | Chinese medicinal composition for treating fatty liver and its preparation method | |
| CN1973878A (en) | Medicine for treating children's stomachache and its prepn | |
| CN1233354C (en) | Chinese medicine preparation for treating carcinoma of esophagus | |
| CN1055227C (en) | Medicine for treating masculine sterility | |
| CN1544032A (en) | Anticancer Chinese traditional extracts and preparation process and application thereof | |
| CN1990033A (en) | Drug for treating hypertension, dense blood and arteriosclerosis | |
| CN1054541C (en) | Traditional Chinese medicine for treating mastosis | |
| CN1050292C (en) | Anticancer drug and preparing method thereof | |
| CN1254267C (en) | Medicine for treating gastral cavity pain and its preparation method | |
| CN1569095A (en) | Medicine for treating cerebral infarction | |
| CN1278732C (en) | Compound formulation of traditional Chinese medicine for assistant treatment of tumour and preparation method thereof | |
| CN1045892C (en) | Chinese medicine Guanxintong for preventing and curing coronary heart disease and angina pectoris, and producing process thereof | |
| CN1537564A (en) | Traditional chinese medicine prepns. for treating broad-spectrum cancers | |
| CN1689637A (en) | Chinese medicinal preparation for treating cardiovascular and cerebrovascular diseases and its preparing process | |
| CN1232283C (en) | Chinese drugs for treatment of coronary heart disease and angina pectoris | |
| CN1593493A (en) | Therapy assisting agent and its preparation | |
| CN1304045C (en) | Arthralgia removing pills and their preparation | |
| CN1634407A (en) | Chinese traditional medicine preparation for treating cholecystitis | |
| CN1304043C (en) | Longhedan pills and their preparation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C06 | Publication | ||
| PB01 | Publication | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |